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Abstract: 
The present study examined the factor structure underlying the
 
Wisconsin Schizotypy Scales and the validity of 
these dimensions.
 
Confirmatory factor analysis with 6137 nonclinical young adults
 
supported a 2-factor model 
with positive and negative schizotypy
 
dimensions. As predicted, the schizotypy dimensions were differentially
 
related to psychopathology, personality, and social impairment.
 
Both dimensions were related to schizotypal 
and paranoid symptoms.
 
Positive schizotypy was uniquely related to psychotic-like experiences,
 
substance 
abuse, mood disorders, and mental health treatment,
 
whereas negative schizotypy was associated with negative 
and
 
schizoid symptoms. Both dimensions were associated with poorer
 
overall and social functioning, but 
negative schizotypy was
 
associated with decreased likelihood of intimate relationships.
 
The findings support the 
construct validity of a multidimensional
 
model of schizotypy and the use of psychometric inventories
 
to assess 
these dimensions.
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Article: 
INTRODUCATION 
It has been more than 30 years since the Chapmans and their
 
collaborators began developing their measures of 
schizotypy
 
or psychosis proneness. Since that time their scales have been
 
widely used with clinical and 
nonclinical samples. However,
 
the scales have typically been used as manifest independent
 
variables, and there 
have been few studies examining whether
 
there is a meaningful factor structure underlying the scales.
 
The 
present study examines the factor structure underlying four
 
of the Wisconsin Schizotypy Scales—the Perceptual 
Aberration,1
 
Magical Ideation,2 Physical Anhedonia,3 and Revised Social Anhedonia
 
(Eckblad ML, Chapman 
LJ, Chapman JP, Mishlove M, unpublished
 
questionnaire, 1982) Scales—and examines the construct
 
validity of 
these dimensions. 
 
SCHIZOTYPY AND SCHIZOPHRENIA 
Current models of the etiology of schizophrenia and related
 
disorders4–7 implicitly or explicitly assume that 
there
 
are schizotypic individuals who have neurodevelopmental vulnerability
 
for developing such conditions. 
Although the exact mechanisms
 
are not fully understood, this vulnerability is presumed to
 
result from an 
accumulation or interaction of multiple genetic,
 
neurodevelopmental, and psychosocial factors. Meehl8 used 
Rado's9
 
term schizotypy to refer to the personality organization that
 
represents the expression of this 
vulnerability. It is assumed
 
that there are individuals who have an underlying vulnerability
 
for schizophrenia but 
who may never decompensate into clinical
 
psychosis. In fact, it is presumed that the majority of these
 
schizotypic individuals will never decompensate, although they
 
may demonstrate mild or transient signs of 
schizophrenic-like
 
or schizotypic adjustment that includes cognitive and biobehavioral
 
deficits, clinical and 
subclinical symptoms, and social impairment.
  
 
This formulation suggests that schizotypy is expressed on a
 
dynamic continuum ranging from relative 
psychological health
 
to subclinical deviance to schizophrenia-spectrum personality
 
disorders to full-blown 
schizophrenia, with severity contingent
 
on the interaction of biopsychosocial factors.10 Because compensated
 
or 
nonpsychotic schizotypes are hypothesized to share a common
 
neurodevelopmental pathway with schizophrenia 
patients, it is
 
expected that they will exhibit subclinical and clinical forms
 
of the cognitive, emotional, and 
behavioral features of schizophrenia.
 
We hypothesize that this impairment can provide points of entry
 
for 
identifying schizotypic individuals. Furthermore, we hypothesize
 
that the identification of schizotypic 
individuals should facilitate
 
the determination of relevant etiological factors and may ultimately
 
hasten the 
development of prophylactic treatment interventions.
 
The study of schizotypy also minimizes many of the 
confounding
 
effects of the consequences of schizophrenia (eg, hospitalization,
 
psychotropic medications, 
marginalized social status) that complicate
 
the study of patients with the disorder.
 
 
 
SCHIZOTYPY AS A MULTIDIMENSIONAL CONSTRUCT 
Schizotypy has been described as a multidimensional construct
 
consisting of 2 or more factors. Consistent with 
multidimensional
 
models of schizophrenia, candidate factors include positive
 
schizotypy, negative schizotypy, 
cognitive disorganization,
 
paranoia, and nonconformity.11–14 Positive and negative
 
schizotypy are the most 
consistently replicated factors. While
 
there is not a universally agreed upon latent structure of schizotypy,
 
the 
proposed factors appear consistent with those hypothesized
 
to comprise schizophrenia, including positive, 
negative, and
 
disorganized dimensions.15–18 Findings of parallel factor
 
structure add empirical support to the 
hypothesis that the neurodevelopmental
 
vulnerability for schizophrenia is expressed across the continuum
 
of 
schizotypy. The identification of a multidimensional structure
 
should provide a model for better understanding 
the heterogeneity
 
that characterizes schizotypy and schizophrenia. Furthermore,
 
the reliable identification of 
these factors should provide
 
an improved basis for exploring the etiological mechanisms that
 
underlie these 
dimensions and the events that impact the progression
 
toward clinical illness. 
 
WISCONSIN SCALES OF SCHIZOTYPY 
Psychometric inventories provide a promising method for assessing
 
schizotypy. First, these measures can be 
used to screen large
 
numbers of individuals from the general population, rather than
 
selecting participants based 
upon clinical status or consanguinity.
 
In contrast, family studies provide a rather stratified group
 
of at-risk 
participants because only about 15% of all patients
 
with schizophrenia have a known first-degree relative with 
the
 
disorder—thus providing a sample that is not wholly representative
 
of future sufferers. Psychometric 
screening inventories also
 
tend to be relatively noninvasive and inexpensive to administer
 
and score. Finally, 
they can be used in conjunction with other
 
measures of risk including family studies—as has been
 
demonstrated 
by research such as the New York High-Risk Project.19
  
 
Loren and Jean Chapman and their collaborators developed a series
 
of self-report, true-false questionnaires that 
were intended
 
to measure symptoms and traits reported to be characteristic
 
of the preschizophrenic condition. 
The development of the scales
 
relied heavily on Meehl's20 description of schizotypy and the
 
description of 
pseudoneurotic schizophrenia by Hoch and Cattell21.
 
These measures include the Magical Ideation, Perceptual 
Aberration,
 
Physical Anhedonia, and Revised Social Anhedonia Scales. The
 
Perceptual Aberration Scale 
contains 35 items that tap schizophrenic-like
 
perceptual and bodily distortions, while the Magical Ideation
 
Scale 
is comprised of 30 items that tap a belief in implausible
 
or invalid causality. The Revised Social Anhedonia 
Scale consists
 
of 40 items that tap asociality and indifference to others.
 
The Physical Anhedonia Scale includes 
61 items that tap deficits
 
in sensory and aesthetic pleasure. The questionnaires were not
 
developed as diagnostic 
instruments or to map on specifically
 
to diagnostic criteria. The Perceptual Aberration and Magical
 
Ideation 
Scales were developed to tap positive schizotypy, while
 
the anhedonia scales were designed to assess aspects of 
negative
 
schizotypy. Surprisingly, the Revised Social Anhedonia Scale
 
appears to tap aspects of both 
dimensions of schizotypy.22 The
 
scales were developed following Jackson's23 recommendations
 
for the 
construction of personality measures resulting in internally
 
consistent questionnaires. 
  
VALIDITY OF THE WISCONSIN SCHIZOTYPY SCALES 
The Wisconsin Schizotypy Scales have been widely used in cross-sectional
 
and longitudinal studies with 
psychotic patients and psychosis-prone
 
subjects. Nonpsychotic individuals with markedly elevated scores
 
on 
these scales tend to show psychological and physiological
 
deficits similar to those seen in schizophrenia 
patients.24,25
 
Chapman et al26 reinterviewed 95% of 534 putatively schizotypic
 
and control participants in a 
10-year longitudinal study. At
 
the follow-up assessment, participants identified by the Perceptual
 
Aberration and 
Magical Ideation Scales had higher rates of psychosis
 
than control participants. In addition, schizotypic 
participants
 
who did not develop psychotic disorders still exceeded the control
 
group on ratings of schizotypal, 
paranoid, and psychotic-like
 
symptoms. Chapman et al26 also examined the degree to which
 
a combination of 
measures improved the prediction of psychosis
 
at the 10-year follow-up. They reported that 14% of Magical
 
Ideation subjects who also reported psychotic-like experiences
 
at the initial assessment developed psychotic 
disorders at the
 
follow-up assessment. Secondly, participants who were deviant
 
on the Magical Ideation Scale 
and scored above the mean on the
 
Revised Social Anhedonia Scale had a 21% rate of psychosis at
 
the follow-up. 
Finally, the rate of psychosis leapt to 40% in
 
the Magical Ideation-Social Anhedonia subjects who also reported
 
psychotic-like experiences at the initial assessment. Kwapil27
 
reported that 24% of individuals scoring high on 
the Revised
 
Social Anhedonia Scale exhibited schizophrenia-spectrum illnesses
 
as compared with 1% of 
controls at a 10-year reassessment. The
 
Physical Anhedonia Scale has not been an effective predictor
 
of 
psychosis in longitudinal studies of college students. However,
 
in cross-sectional research, high scorers on the 
scale exhibited
 
cognitive, social, and physiological deficits similar to schizophrenic
 
patients. Moreover, the New 
York High Risk Project19 found that
 
the offspring of schizophrenic patients who had elevated scores
 
on the 
Physical Anhedonia Scale showed increased rates of psychosis
 
and social impairment. These findings support 
the validity of
 
the construct of schizotypy and the use of the Perceptual Aberration,
 
Magical Ideation, and 
Revised Social Anhedonia Scales as indicators
 
of the construct. 
 
GOALS AND HYPOTHESES OF THE PRESENT STUDY 
The initial goal of the present study was to examine the underlying
 
factor structure assessed by the Wisconsin 
Schizotypy Scales
 
in a large nonclinical sample of young adults. We hypothesized
 
that a 2-factor solution would 
provide the best fit with the
 
data. Specifically, it was expected that the 2 anhedonia scales
 
would load on a 
negative schizotypy factor, while the Perceptual
 
Aberration and Magical Ideation Scales would load on a 
positive
 
schizotypy factor. We further expected, consistent with previous
 
questionnaire and interview studies, 
that the best fitting model
 
would involve the Revised Social Anhedonia Scale cross-loading
 
onto the positive 
schizotypy factor as well. We hypothesized
 
that this factor structure would be invariant across sex and
 
between 
Caucasian and African American participants. Assuming
 
that there was a discernable factor structure, we 
planned to
 
compute dimensional scores for each of the participants.
 
 
The second goal of the study was to provide a preliminary examination
 
of the validity of the schizotypy 
dimensions by exploring the
 
relationship of the factor structure with interview and questionnaire
 
measures of 
schizotypy, psychopathology, personality, and adjustment.
 
We hypothesized that the positive and negative 
schizotypy factors
 
would be differentially related to these measures. Specifically,
 
we predicted that the positive 
dimension would be significantly
 
related to interview measures of psychotic-like, schizotypal,
 
and paranoid 
symptoms as well as mood disorders, substance use,
 
and history of mental health treatment. The negative 
dimension
 
was expected to be associated with ratings of negative, schizotypal,
 
and schizoid symptoms and 
poorer overall functioning but not
 
with mood disorders or substance use. It was expected that the
 
interaction of 
both schizotypy dimensions would improve the
 
prediction of overall functioning and schizotypic symptoms 
beyond
 
the main effects. We hypothesized that the positive symptom
 
dimension would be associated with 
questionnaire measures of
 
neuroticism and openness to experience, while the negative symptom
 
dimension 
would be inversely associated with extraversion and
 
openness to experience. Both dimensions were presumed to 
be
 
related to impairment in social functioning across multiple
 
domains.
 
 
METHOD 
Participants 
Usable schizotypy questionnaires were completed by 6137 college
 
undergraduates enrolled in introductory 
psychology courses at
 
the University of North Carolina at Greensboro (UNCG) between
 
1998 and 2005. The 
mean age of the sample was 19.4 years (SD
 
= 3.7). The sample was limited to Caucasian and African American
 
participants because reliable norms for the schizotypy scales
 
have not been established for other ethnic groups 
and because
 
other ethnic groups comprised less than 2% of the sample of
 
participants. Consistent with the 
student demographics at UNCG,
 
the sample was 76% female and 24% male and 74% Caucasian and
 
26% 
African American. Males and females did not differ on age
 
or ethnicity.
 
 
An unselected subset of 780 participants completed questionnaire
 
measures of personality and social 
functioning following completion
 
of the schizotypy scales. The subsample was comparable to the
 
original 
sample with 75% female and 25% male and 78% Caucasian
 
and 22% African American. The participants who 
completed the
 
questionnaires did not differ from the remaining participants
 
in the initial sample on their scores 
on the schizotypy scales.
 
Likewise, a subset of 430 participants were administered structured
 
diagnostic 
interviews. The subsample was comparable to the original
 
sample with 74% female and 26% male and 74% 
Caucasian and 26%
 
African American. The participants were recruited for interviews
 
based upon their scores on 
the schizotypy scales as part of
 
several different studies conducted at UNCG. The means on the
 
schizotypy 
scales were slightly higher in the interviewed sample
 
than in the noninterviewed sample; however, the 
distribution
 
and range of scores were comparable between the 2 groups. Subjects
 
provided informed consent and 
received course credit for participation
 
in each part of the study. The study was approved by the UNCG
 
Institutional Review Board and conducted in accordance with
 
the American Psychological Association Code of 
Ethics.
 
 
Materials and Procedures 
Schizotypy Questionnaires. Participants were administered the Perceptual Aberration, Magical
 
Ideation, Revised 
Social Anhedonia, and Physical Anhedonia Scales.
 
The items on the schizotypy scales were intermixed with a 
13-item
 
measure of infrequent responding (Chapman LJ, Chapman JP, unpublished
 
questionnaire, 1983). The 
infrequency scale was included to
 
screen out participants who responded in a random or "fake-bad"
 
manner. 
Consistent with the recommendations of Chapman and Chapman
 
(Chapman LJ, Chapman JP, unpublished 
questionnaire, 1983), participants
 
who endorsed more than 2 infrequency items were dropped from
 
further 
study. Participants completed these measures (along
 
with measures not used in this study) as part of mass-
screening
 
sessions that lasted 1.5–2 hours.
 
 
Personality and Social Adjustment Question-naires. Participants completed the NEO Personality Inventory-
Revised28
 
(NEO-PI-R) and the Social Adjustment Scale—self-report
 
version.29 The NEO-PI-R is a widely 
used self-report measure
 
of the 5-factor model of personality. It is broken down into
 
5 domains, each of which 
has 6-facet scores. The scale contains
 
240 items, which are scored on a 5-point Likert scale from "Strongly
 
Agree" to "Strongly Disagree." The Social Adjustment Scale is
 
a 54-item self-report measure that assesses 
functioning in a
 
variety of social contexts. The scale provides a total score
 
and 3 subscale scores applicable to 
college students that assess
 
social functioning in school during social and leisure activities
 
(including friendships 
and dating) and with extended family.
 
Each question is rated on a 5-point scale with higher scores
 
indicating 
greater impairment.
 
 
Structured Interviews. The interview contained the portions of the Structured Clinical
 
Interview for the 
Diagnostic and Statistical Manual of Mental
 
Disorders, Fourth Edition,30 that assess major depressive and
 
manic episodes, substance use disorders, and demographic information.
 
Quantitative ratings of substance use 
and impairment were coded
 
using the rating system described in Kwapil.31 The modules of
 
the International 
Personality Disorders Examination32 that assess
 
schizoid, paranoid, and schizotypal personality disorders were
 
also included. These personality disorders were assessed because
 
they are reported to be genetically related to 
schizophrenia.33–35
 
The International Personality Disorders Examination provides
 
personality disorders 
diagnoses and dimensional ratings of the
 
disorders.
 
 
The Wisconsin Manual for Assessing Psychotic-like Experiences36,37
 
was used to quantify the deviance of 
psychotic symptoms across
 
a broad range of clinical and subclinical deviancy. The manual
 
provides criteria for 
rating 7 classes of experiences on a continuum
 
from relatively normal to grossly psychotic, including (1) 
transmission
 
of one's own thoughts, (2) passivity experiences, (3) thought
 
withdrawal, (4) voice experiences and 
other auditory hallucinations,
 
(5) other personally relevant aberrant beliefs, (6) visual hallucinations
 
and other 
visual experiences, and (7) olfactory experiences.
 
Experiences of mild or transient forms of psychotic symptoms
 
in nonpsychotic persons have historically been thought of as
 
precursors of clinical psychosis.21,38–40 Kwapil 
et al37
 
reported that the highest rating across the 7 classes of experiences
 
provides a useful index of clinical and 
subclinical deviancy,
 
and it effectively predicts the development of psychotic disorders.
 
Interrater reliability is 
0.89 for the highest symptom rating.
 
 
The Negative Symptom Manual (Kwapil TR, Dickerson LA, unpublished
 
data, 2001), which provides a 
companion rating system to the
 
Wisconsin Manual, was used to quantify negative symptoms of
 
schizophrenia 
across a range of clinical and subclinical deviance.
 
The manual consists of a structured interview and rating 
system
 
that assesses 6 classes of symptoms across a range of clinical
 
and subclinical deviance: alogia, flattened 
affect, anhedonia,
 
social indifference, avolition/anergia, and impairment in attention
 
(as well as producing a total 
score). Interrater reliability
 
is 0.94 for the Negative Symptom Manual total score. The Global
 
Assessment Scale 
(GAS)41 was used to assess overall functioning
 
for each subject. The GAS is a rating of overall adjustment
 
ranging from marked psychopathology at the low end to superior
 
functioning at the high end. Interrater 
reliability was 0.87
 
for the GAS ratings.
 
 
The interviews were conducted by a licensed clinical psychologist
 
and advanced graduate students in clinical 
psychology. The assessments
 
were audiotaped and lasted approximately 2 hours. The interviewers
 
were 
unaware of participants’ scores on the schizotypy
 
questionnaires.
 
 
RESULTS 
Descriptive and Correlational Analyses for the Schizotypy Scales 
Table 1 contains descriptive statistics for each of the schizotypy
 
scales computed separately by gender and 
ethnicity. Two-way
 
(group by ethnicity) analyses of variance were conducted for
 
each of the 4 scales. The alpha 
level was set at 0.001 for the
 
analyses due to the large sample size and the large number of
 
analyses computed in 
order to minimize Type I error and to reduce
 
the likelihood of reporting statistically significant but 
inconsequential
 
findings (ie, findings that accounted for a trivial amount of
 
variance). Nevertheless, the large 
sample size renders the interpretation
 
of conventional p values problematic. Therefore, the eta2 effect
 
size is 
reported and may be more instructive for considering
 
the relative contribution of each effect. This statistic 
indicates
 
the proportion of the total variance in the sample accounted
 
for by each effect. Following Cohen,42 an 
effect size of 0.14
 
is considered large, 0.06 is considered medium, and 0.01 is
 
considered small. None of the 
interaction effects accounted
 
for more than 0.1% of the variance. The only main effect that
 
accounted for a 
nontrivial portion of the variance was the main
 
effect of ethnicity on the Physical Anhedonia Scale (small effect
 
size). Contrary to previous recommendations,43 raw scores on
 
the schizotypy scales (rather than scores normed 
on sex and
 
ethnicity) were used for the subsequent analyses—given
 
the minimal effect of these variables on the 
schizotypy scores. 
Table 1. Descriptive Statistics for the Schizotypy Scales by Sex and Ethnicity  
 African American 
 
Caucasian 
 
 Main Effects 
 
 
 Male Female Male Female     
 (n = 299) (n = 1309) (n = 1174) (n = 3355)  Sex Ethnicity Interaction 
 
Perceptual Aberration Scale 
 
Mean 6.67 5.89 5.93 5.66 F value 6.9 6.0 1.6 
SD 5.93 4.82 5.74 5.69 p value .009 .015 >.10 
 
.89 .84 .89 .89 
2
 <.001 <.001 <.001 
Magical Ideation Scale 
 
Mean 10.56 9.92 9.29 9.06 F value 4.7 27.3 1.0 
SD 5.45 5.13 5.61 5.75 p value .031 <.001 >.10 
 
.84 .84 .89 .90 
2
 <.001 .001 <.001 
Physical Anhedonia Scale 
 
Mean 18.28 16.29 14.39 10.68 F value 144.0 400.0 13.2 
SD 7.12 6.57 7.77 5.99 p value <.001 <.001 <.001 
 
.80 .79 .86 .81 
2
 .005 .013 <.001 
Revised Social Anhedonia Scale 
 
Mean 11.38 10.23 9.64 7.23 F value 78.3 137.4 9.7 
SD 5.74 5.46 6.27 5.34 p value <.001 <.001 .002 
 
.81 .81 .85 .84 
2
 .004 .007 <.001 
 
Note: df = 1, 6133 for all analyses. 
Table 2 presents the Pearson correlations of the scales for
 
the total sample. According to Cohen42 correlations 
of 0.10
 
indicate small effect sizes, 0.30 indicate medium effect sizes,
 
and 0.50 indicate large effect sizes (with 
squared correlation
 
coefficients indicating the amount of variance shared or accounted
 
for in the bivariate 
relationship). Consistent with previous
 
findings,44 the Perceptual Aberration and Magical Ideation Scales
 
were 
highly correlated, as were the Social Anhedonia and Physical
 
Anhedonia scales. The Physical Anhedonia Scale 
was not correlated
 
with Perceptual Aberration or Magical Ideation scores. The Revised
 
Social Anhedonia Scale 
was significantly, though modestly, correlated
 
with the Perceptual Aberration and Magical Ideation Scales—
consistent
 
with the finding that the Revised Social Anhedonia Scale taps
 
aspects of both positive and negative 
schizotypy. The pattern
 
of correlations was comparable when computed separately by sex
 
and ethnicity. 
 
Table 2. Pearson Correlations and Reliabilities of the Schizotypy Scales for the Total Sample (n = 6137)  
 Perceptual 
Aberration 
Magical 
Ideation 
Physical 
Anhedonia 
Revised Social 
Anhedonia 
 
Perceptual Aberration 0.88    
Magical Ideation 0.69 0.84   
Physical Anhedonia –0.03 –0.10 0.84  
Revised Social 
Anhedonia 
0.29 0.22 0.42 0.84 
 
Note: Coefficient alpha presented along the diagonal. 
Confirmatory Factor Analyses 
Confirmatory factor analyses (CFAs) were conducted to examine
 
the factor structure of psychometrically 
assessed schizotypy.
 
The sample size and the number of participants per observable
 
variable were more than 
sufficient for conducting CFA.45,46
 
The items for each of the schizotypy scales were divided into
 
3 "parcels" in 
order to produce more robust estimates.48 Following
 
the recommendations of Little et al. (2002), each of the 
scales
 
was divided into 3 parcels by randomly distributing groups of
 
3 items to the parcels in sequential order to 
ensure that each
 
parcel contained a comparable proportion of items from the beginning,
 
middle, and end of the 
scale. The coefficient alphas of the
 
parcels ranged from 0.56 to 0.75 (mean = 0.65), consistent with
 
the 
estimations computed using the Spearman-Brown prophecy formula
 
for the effects of shortening the measures 
to this degree. While
 
each parcel had lower reliability than the original measures,
 
they allowed us to produce a 
more robust estimate of our latent
 
constructs. The residuals from each parcel within a schizotypy
 
scale were 
allowed to correlate given the common source. Goodness
 
of fit was assessed using multiple indicators listed in 
table 3,
 
including the goodness of fit index, adjusted goodness of fit
 
index, normed fit index, comparative fit 
index, root mean square
 
error of approximation, and the chi-square statistic. Adequate
 
fit of the model to the 
data is generally indicated by fit indices
 
greater than 0.95, root mean square error of approximation less
 
than 
0.05, and nonsignificant chi-squares47,48; however, with
 
a large sample, it is unlikely to report a nonsignificant 
value.
 
 
Table 3. Confirmatory Factor Analyses of Schizotypy Scale Parcels (n = 6137)  
Model GFI AGFI NFI CFI RMSEA RMSEA 
CI 
Chi-
square 
(df) 
p 
value 
2
 (
df) 
p 
value 
 
Factor Structure for the Total Sample 
 
 
Unidimensional 0.90 0.82 0.92 0.92 0.111 0.108–
0.114 
3295.0 
(43) 
<.001   
 
2-Factor
a
 0.98 0.96 0.98 0.98 0.053 0.050–
0.056 
772.6 
(42) 
<.001   
 
2-Factor
b
 0.99 0.99 0.99 0.99 0.032 0.029–
0.036 
285.3 
(39) 
<.001 487.3 
(3) 
<.001 
 
Factor Invariance across Sex and Ethnicity 
  
Unconstrained 0.98 0.98 0.99 0.99 0.017 0.015–
0.019 
558.2 
(202) 
<.001   
 
Regression Weights 
Constrained 
0.98 0.98 0.98 0.99 0.017 0.016–
0.019 
680.3 
(241) 
<.001   
 
Structural Covariances 
Constrained 
0.98 0.97 0.98 0.98 0.020 0.018–
0.021 
841.1 
(273) 
<.001   
 
 
Note: GFI, Goodness of Fit Index; AGFI, Adjusted Goodness of Fit Index; NFI, Normed Fit Index; CFI, 
Comparative Fit Index; RMSEA, Root Mean Square Error of Approximation; RMSEA CI, 90% confidence 
interval for RMSEA.  
a
 Positive schizotypy factor (with loadings from the Perceptual Aberration and Magical Ideation Scales) and 
negative schizotypy factor (with loadings from the Revised Social Anhedonia and Physical Anhedonia Scales).  
b
 Positive schizotypy factor (with loadings from the Perceptual Aberration, Magical Ideation and Revised Social 
Anhedonia Scales) and negative schizotypy factor (with loadings from the Revised Social Anhedonia and 
Physical Anhedonia Scales). 
Three models were tested to examine factor structure. The first
 
(default) model did not differentiate an 
underlying factor structure
 
for schizotypy—all the variables loaded on a generic schizotypy
 
factor. As seen in 
table 3, the fit for this model was poor.
 
The second model included a positive schizotypy factor with
 
loadings 
from the Perceptual Aberration and Magical Ideation
 
Scale parcels and a negative schizotypy factor with 
loadings
 
from the Revised Social Anhedonia and Physical Anhedonia Scale
 
parcels. The schizotypy factors 
were allowed to correlate in
 
this and the subsequent models. This model provided improved
 
fit for the data but 
still failed to provide adequate fit. The
 
final model was the same as the previous, except that the Revised
 
Social 
Anhedonia Scale was allowed to load on both the schizotypy
 
factors. This 2-factor model provided an excellent 
fit for the
 
data. Given that the final 2 models were nested, the change
 
in chi-square and degrees of freedom was 
evaluated between them.
 
The final model provided significantly improved fit over the
 
second model. Figure 1 
contains the standardized coefficients
 
for the final model. 
 
 
Fig. 1. Two-factor solution with standardized coefficients.  
 
In order to test the invariance of the factor structure across
 
sex and ethnicity, a multigroup, multimodel 
comparison was conducted
 
using the final 2-factor structure reported above. In the first
 
model, the subscales 
were allowed to freely load on the schizotypy
 
factors for each of the 4 sex-by-ethnicity groups (eg, African
 
American females). In the second model, the regression weights
 
(but not the structural covariances) were 
constrained to be
 
identical across the 4 sex/ethnicity groups. The final model
 
was the most restrictive in that it 
constrained the factor variances
 
and covariances, in addition to the regression weights, across
 
the 4 groups. As 
seen in table 3, the 2 constrained models fit
 
the data equally as well as the model in which the factor loadings
 
were allowed to vary freely, supporting the comparability of
 
the factor structure of psychometrically assessed 
schizotypy
 
across sex and ethnicity.
 
 
Bootstrap Procedures 
As noted in Chapman et al,43 the distributions of scores for
 
their scales depart from normality. Following the 
recommendation
 
of Wilcox and Muska,49 the correlations reported in table 2
 
and the final CFA model reported 
in table 3 were computed using
 
bootstrap procedures. In each case, the analysis was computed
 
using 1000 
bootstrap samples and the difference (bias) between
 
the original coefficients and the bootstrapped coefficients
 
was computed. In every reanalysis, all 1000 bootstrap samples
 
were usable. The bias values for the correlations 
presented
 
in table 2 were within ±0.001 in every case, supporting
 
the original estimates. Likewise, the bias was 
minimal for the
 
standardized regression weights (bias range: 0.000–0.004)
 
and the correlation coefficient 
(0.003) in the CFA. The results
 
of the bootstrap analyses support the findings of the original
 
analyses.
 
 
Validity of the Schizotypy Factors 
Positive and negative schizotypy dimensional scores were computed
 
for each subject based upon the factor 
weights derived from
 
the final CFA. In order to provide a preliminary examination
 
of the validity of the 
schizotypy dimensions, a series of hierarchical
 
linear and binary logistic regression analyses were computed
 
assessing the relative contribution of each of the schizotypy
 
dimensions and their interaction to the prediction of 
interview
 
measures of psychopathology and questionnaire measures of personality
 
and adjustment. In every 
analysis, the positive and negative
 
schizotypy factor scores were entered simultaneously in the
 
regression at the 
first step in order to examine the relative
 
contribution of each factor, while controlling for the other
 
factor (this 
in essence creates an "equal horse race" in which
 
the variance accounted for by each factor is examined 
independent
 
of the other factor). The interaction term was always entered
 
at the second step to assess its effect 
over and above the main
 
effects (however, note that contrary to our hypotheses none
 
of the interaction terms 
accounted for a significant increment
 
in variance). The standardized regression coefficient (β)
 
and semipartial r
2
 
for each predictor was reported for continuous
 
dependent measures. Binary logistic regression was computed
 
in 
the case of dichotomous, dependent variables with the odds
 
ratios and 95% confidence intervals reported.
 
 
Relationship With Interview Measures of Psychopathology. Table 4 presents the relationship of the positive and 
negative
 
schizotypy factors with interview measures of psychopathology.
 
As expected, both dimensions were 
associated with poorer overall
 
adjustment. Consistent with our predictions, the negative schizotypy
 
dimension 
was significantly associated with interview ratings
 
of negative, schizotypal, schizoid, and paranoid but not 
psychotic-like
 
(positive) symptoms. Negative schizotypy was also associated
 
with never having a steady 
intimate relationship. Consistent
 
with the idea that negative schizotypy is associated with blunted
 
affect and 
diminished sensation seeking, the factor score was
 
not significantly associated with mood episodes or substance
 
use. Furthermore, negative schizotypy was unrelated to history
 
of mental health treatment. Positive schizotypy 
was generally
 
associated with a different pattern of impairment. Specifically,
 
the dimension was associated with 
elevated ratings of psychotic-like,
 
schizotypal, and paranoid (but not schizoid or negative) symptoms.
 
It also 
was significantly associated with mood episodes, increased
 
substance use and abuse, history of psychiatric 
hospitalization,
 
outpatient mental health treatment, and pharmacotherapy.
 
 
 
Table 4. Linear and Logistic Regressions of the Interview Measures of Psychopathology (n = 430)  
Multiple linear regressions 
 
 Step 1 
 
Step 2 
 
 Positive Schizotypy 
 
Negative Schizotypy 
 
Interaction 
 
Criterion β r
2
 β r
2
 β r
2
 
 
Global Adjustment Scale –.348 0.116
*
 –.268 0.066
*
 .044 0.002 
Psychotic-like experiences .534 0.285
*
 .060 0.004 –.026 0.001 
Schizotypal symptoms .424 0.180
*
 .181 0.033
*
 .020 0.000 
Schizoid symptoms .091 0.008 .445 0.198
*
 .071 0.005 
Paranoid symptoms .206 0.042
*
 .203 0.041
*
 .062 0.004 
Alcohol use .160 0.025
*
 –.048 0.002 –.081 0.006 
Alcohol impairment .221 0.049
*
 –.065 0.004 –.112 0.011 
Drug use .362 0.131
*
 –.076 0.006 –.100 0.009 
Drug impairment .333 0.111
*
 –.075 0.006 –.075 0.005 
 
Binary logistic regressions 
 
 Step 1 
 
Step 2 
 
 Positive Schizotypy 
 
Negative Schizotypy 
 
Interaction 
 
Criterion OR 95% CI OR 95% CI OR 95% CI 
 
No steady relationship 0.89 0.74–1.11 1.28
*
 1.09–1.50 1.03 0.90–1.13 
Major depressive episode 1.54
*
 1.30–1.84 .88 0.72–1.07 0.92 0.79–1.07 
Manic episode 3.26
*
 1.62–6.59 1.18 0.56–2.46 1.44 0.72–2.87 
Psychiatric treatment 
 
    Hospitalization 2.04
*
 1.37–3.04 1.23 0.78–1.93 1.03 0.74–1.44 
    Outpatient 1.47
*
 1.24–1.74 .88 0.73–1.06 1.05 0.90–1.22 
    Medication 1.49
*
 1.21–1.82 1.06 0.85–1.32 1.27 1.05–1.53 
First or second degree relative 
 
    With psychosis 1.31 0.96–1.78 1.09 0.79–1.53 .88 0.70–1.11 
    With nonpsychotic illness 1.24 1.07–1.43 .94 0.82–1.09 .96 0.85–1.09 
 
Note: df for all linear regressions: Step 1 = 1, 428; Step 2 = 1, 427; Step 3 = 1, 426. CI, confidence interval.  
*p < .001. 
Relationship With Questionnaire Measures of Personality and Social Functioning. Table 5 presents the 
standardized regression coefficient (β)
 
and semipartial r
2
 for the positive schizotypy, negative schizotypy,
 
and 
interaction terms in the prediction of scores on the Social
 
Adjustment Scale total and subscale scores and the 
NEO-PI-R
 
domain scores. Both schizotypy dimensions were associated with
 
overall ratings of social 
impairment. Positive schizotypy was
 
associated with social impairment in school, leisure, and family
 
settings, 
whereas negative schizotypy was only associated with
 
impairment in leisure and family settings. Positive 
schizotypy
 
was associated with increased neuroticism and decreased agreeableness
 
and conscientiousness. 
Negative schizotypy was associated with
 
introversion (low extraversion) and decreased agreeableness.
 
The 
distinction between positive and negative schizotypy was
 
best captured by openness to experience because 
positive schizotypy
 
was positively associated with the domain, while negative schizotypy
 
had an inverse 
relationship (each schizotypy dimension independently
 
accounted for more than 10% of the variance in 
openness).
 
 
Table 5. Linear Regressions of the Questionnaire Measures of Personality and Adjustment (n = 780)  
 Step 1 
 
Step 2 
 
 Positive Schizotypy 
 
Negative Schizotypy 
 
Interaction 
 
Criterion β r
2
 β r
2
 β r
2
 
 
Social Adjustment Scale 
 
    Total .260 0.065
*
 .222 0.048
*
 .019 0.001 
    Student .221 0.048
*
 .030 0.001 .024 0.001 
    Leisure .122 0.014
*
 .289 0.081
*
 .019 0.001 
    Family .250 0.061
*
 .120 0.015
*
 .035 0.001 
NEO-PI-R 
 
    Neuroticism .350 .119
*
 .030 .001 .047 .002 
    Extraversion –.061 0.004 –.528 0.271
*
 –.068 0.004 
    Openness to experience .333 0.108
*
 –.400 0.155
*
 .053 0.003 
    Agreeableness –.177 0.030
*
 –.256 0.064
*
 .014 0.001 
    Conscientiousness –.222 0.048
*
 .035 0.001 .036 0.001 
 
Note: df for all linear regressions: Step 1 = 1, 778; Step 2 = 1, 777; Step 3 = 1, 776.  
*p < .001. 
DISCUSSION 
The identification of schizotypic individuals holds the promise
 
of advancing our understanding of the 
neurodevelopmental and
 
psychosocial processes that produce schizotypy and that exacerbate
 
or provide 
protection against the development of schizophrenia
 
and spectrum disorders. Furthermore, it is an essential step
 
in the development of preventative treatment programs—interventions
 
that are currently controversial due to our 
limited ability
 
to accurately identify individuals at risk of developing such
 
disorders and our lack of 
understanding about which interventions
 
are truly prophylactic.
 
 
Consistent with the current literature, we hypothesized that
 
schizotypy (and by extension schizophrenia) is 
expressed across
 
multiple dimensions—although the exact number, nature,
 
etiology, and interrelationships of 
these dimensions are not
 
unequivocally established. Furthermore, we suggested that the
 
psychometric method 
provides an effective and noninvasive vehicle
 
for assessing at least some of these schizotypic dimensions—or
 
more colloquially, for getting one's foot in the schizotypy
 
door. The present article focused on the Wisconsin 
Schizotypy
 
Scales. However, it should be noted that there are a number
 
of other valuable screening 
questionnaires that have been widely
 
used, including the Schizotypal Personality Questionnaire,50
 
the 
Schizotypal Trait Assessment,51 Oxford-Liverpool Inventory
 
of Feelings and Experiences (O-LIFE),52 and the 
Rust Inventory
 
of Schizotypal Cognitions.53 The goal of the present work was
 
not to reify particular 
measures—in fact, we suggest that
 
both the promising features and the shortcomings of the Wisconsin
 
Scales 
likely apply to many of the other available psychometric
 
screening measures. Rather, the goals were to clarify 
the constructs
 
underlying these scales and to assess their validity.
 
 
Consistent with the multidimensional view of schizotypy, the
 
CFAs supported a 2-factor structure underlying 
the Wisconsin
 
Schizotypy Scales in late adolescence and early adulthood—a
 
structure that was invariant across 
sex and ethnicity. Note
 
that the finding that the CFAs only identified positive and
 
negative dimensions of 
schizotypy was not meant to imply that
 
there are only 2 factors underlying the construct. Positive
 
and negative 
symptom dimensions are the most widely reported
 
factors of schizotypy and schizophrenia; however, our focus
 
on and identification of these factors admittedly reflects the
 
nature of the measures administered. Note that we 
did not test
 
any model with more than 2 factors because meaningful hypotheses
 
could not be offered supporting 
3- or 4-factor models using
 
these questionnaires. However, we believe that identification
 
and validation of 
additional dimensions are essential for furthering
 
our understanding of schizotypy.
 
 
There is considerable controversy regarding the underlying nature
 
of schizotypy. The predominately European 
notion of schizotypy,
 
as espoused by Claridge,54 considers schizotypy to be a normal
 
dimension of personality 
(fully dimensional model), while the
 
predominately North American conceptualization of schizotypy,
 
as set 
forth by Meehl,8 considers schizotypy to represent the
 
expression of a pathological process of 
neurodevelopment that
 
is taxonic in nature. Lenzenweger and Korfine55 and Lenzenweger
 
et al56have used 
taxometric methods and finite mixture modeling
 
to support the notion of a schizotypic taxon.55,56 However,
 
both the North American and European conceptualizations are
 
consistent with a multifactorial structure for 
schizotypy in
 
which schizotypic traits are distributed across continua of
 
increasing severity. The models differ 
on whether these dimensions
 
are continuous or discontinuous with the general population.
 
It is important to note 
that the present study focused on identifying
 
and validating the dimensional structure underlying the Wisconsin
 
Scales not resolving the issue of whether schizotypy is fully
 
dimensional or taxonic in nature—although the 
reliable
 
identification of these underlying dimensions should facilitate
 
resolution of this larger issue.
 
 
What Are We Tapping With Psychometric Scales of Positive and Negative Schizotypy? 
The dimensions of positive and negative schizotypy were predictably
 
related to a variety of interview and 
questionnaire measures
 
of psychopathology and functioning. However, there were also
 
expected areas of 
overlap in these relationships, such that
 
both dimensions were associated with impairment in overall and
 
social 
functioning and with interview ratings of schizotypal
 
and paranoid symptoms. First, significant deviance in any 
personality
 
dimension in general, and in any schizotypy dimension in particular,
 
would likely be associated with 
impairments in functioning—especially
 
social functioning. Second, schizotypal symptoms as defined
 
in 
Diagnostic and Statistical Manual of Mental Disorders include
 
a mix of positive and negative symptoms in the 
cognitive-perceptual,
 
social, and motivational domains. Finally, paranoid symptoms
 
have been found to load on 
different factors in different studies
 
as well as being reported as a separate factor of schizotypy.
 
 
The relationship of the schizotypy dimensions with measures
 
of personality and psychopathology were 
consistent with the
 
analogous symptom dimensions in full-blown schizophrenia. Endorsement
 
of positive 
schizotypic traits on psychometric screening inventories
 
was associated with schizophrenic-like 
psychopathology across
 
a broad range of clinical and subclinical deviancy. In particular,
 
positive traits were 
associated with interview ratings of psychotic-like
 
experiences—experiences that in their extreme form manifest
 
as first-rank symptoms of schizophrenia. As hypothesized, positive
 
schizotypy scores were associated with high 
levels of neuroticism
 
and openness to experience and with low levels of agreeableness
 
and conscientiousness.
 
 
Positive schizotypy also predicted history of manic and depressive
 
episodes, increased substance use and abuse, 
and psychiatric
 
treatment. The relationship of positive schizotypy with manic
 
and depressive episodes is 
consistent with the clinical and
 
empirical literature for schizotypy, schizophrenia, and spectrum
 
disorders. 
Depression and anxiety are significantly associated
 
with positive schizotypy (but not with negative schizotypy)
 
in nonclinical young adults when measured cross-sectionally.22
 
Likewise, Chapman et al26 found that young 
adults identified
 
by the Perceptual Aberration and Magical Ideation Scales had
 
markedly elevated rates of mood 
disorders at a 10-year follow-up
 
assessment relative to control and anhedonic participants. Similarly,
 
a 1-year 
follow-up of participants from the general population
 
found that individuals with high scores on an inventory of 
delusions
 
were 9 times more likely to report an episode of depression
 
during the follow-up period.57 Clearly, 
affective dysregulation
 
and disorders occur across the continuum of schizotypy—and
 
this affective 
dysregulation appears to be best conceptualized
 
as part of the positive schizotypy dimension.
 
 
The finding that positive schizotypy was associated with mania
 
and hypomania is consistent with Claridge and 
colleagues52 conceptualization
 
of positive schizotypy. Claridge54 noted the relationship of
 
schizotypy with 
affective instability characteristic of borderline
 
personality and cyclothymia, and items assessing hypomania 
were
 
included in the unusual experiences factor of the O-LIFE. The
 
present findings are also consistent with the 
similarities in
 
symptoms and genetic liability between mood and nonmood psychoses58
 
and in line with the 
classical Einheit psychoses or unitary
 
psychoses concept that affective and nonaffective psychoses
 
actually lie 
on a continuum.59
 
 
Endorsement of negative schizotypy was associated with interview
 
ratings of negative and schizoid symptoms 
as well as with never
 
having been engaged in a steady relationship. There was not
 
an association between 
negative schizotypy and mood episodes,
 
despite the greater phenotypic resemblance of depression to
 
negative 
than positive schizotypy (eg, apathy, social withdrawal,
 
anhedonia). Previous studies examining symptom 
dimensions in
 
schizotypy22 and schizophrenia60 consistently report a much
 
stronger relationship of mood 
symptoms with the positive, than
 
the negative, dimension. These data and clinical observation
 
seem to point out 
that unlike positive schizotypy, negative
 
schizotypy is associated with a reduced experience of affective
 
tone 
and reactivity.22
 
 
In terms of personality, negative schizotypy scores were associated
 
with introversion, low openness to 
experience, and low agreeableness.
 
The differentiation of positive and negative schizotypy on openness
 
to 
experience is consistent with suggestion of Costa and Widiger61
 
that schizoid and schizotypal pathology may 
be distinguishable
 
by the profile of their scores on this domain. This pattern
 
of differential relationships across 
these domains (psychopathology,
 
personality, social) validates these constructs and indicates
 
the usefulness of 
the current psychometric inventories to capture
 
schizotypy in nonclinical populations. Consistent with 
Claridge's54
 
fully dimensional model of schizotypy, some researchers have
 
suggested that openness to 
experience may be a "nonpathological
 
counterpart to positive schizotypy" that includes expressions
 
such as 
creativity62 and out-of-body experiences.63
 
 
Contrary to our expectations, the interaction between positive
 
and negative schizotypy did not improve our 
prediction of psychopathology
 
or functioning. This is in contrast to findings from cluster-analytic
 
studies that 
participants classified as being high in both positive
 
and negative schizotypy exhibited broader and markedly 
more
 
severe impairment than individuals characterized by only positive
 
or negative schizotypy.64
 
 
Social Anhedonia as a Component of Both Positive and Negative Schizotypy 
The 2-factor model in which the Revised Social Anhedonia Scale
 
loaded exclusively on the negative schizotypy 
factor along with
 
the Physical Anhedonia Scale did not provide as good of a fit
 
to the data because the final 
model in which the Revised Social
 
Anhedonia Scale was allowed to load on both the positive and
 
negative 
schizotypy factors. From a conceptual standpoint, social
 
anhedonia is part of negative schizotypy, which is 
characterized
 
by diminished affect and avolition—in sharp contrast to
 
the behavioral and affective excesses 
associated with positive
 
schizotypy. However, the present finding is consistent with
 
the modest positive 
correlation of the Revised Social Anhedonia
 
Scale with measures of positive schizotypy reported here and
 
elsewhere65 and with interview assessments of participants identified
 
by deviantly high scores on the scale. 
Kwapil27 reported that
 
socially anhedonic college students exhibited elevated rates
 
of schizophrenia-spectrum 
disorders and psychotic-like symptoms
 
at a 10-year follow-up assessment. Similarly, Diaz et al66 reported
 
that 
social anhedonia participants exceeded control participants
 
on interview-based ratings of psychotic-like and 
negative symptoms.
 
In both studies, the findings were independent of scores on
 
the Magical Ideation and 
Perceptual Aberration Scales. In contrast,
 
high scorers on the Perceptual Aberration and Magical Ideation
 
Scales 
only reported elevated rates of psychotic-like, but not
 
negative, symptoms, while high scorers on the Physical 
Anhedonia
 
Scale only reported negative symptoms.67 These findings are
 
especially striking considering that the 
items on the Revised
 
Social Anhedonia Scale simply inquire about disinterest in social
 
contact—none of the 
items assess unusual perceptual experiences
 
or magical beliefs.
 
 
The finding that the Revised Social Anhedonia Scale taps both
 
positive and negative schizotypy dimensions 
calls into question
 
either our conceptual understanding of social anhedonia or our
 
methodological understanding 
of what the scale actually assesses.
 
The relationship between the positive and negative schizotypy
 
dimensions in 
our final 2 models differed considerably depending
 
upon whether the scale was allowed to cross load on both 
dimensions
 
(the factors were orthogonal in the cross-loaded model but positively
 
correlated in the model in 
which social anhedonia only loaded
 
on negative schizotypy). Again, this becomes a question of whether
 
the 
shared variance best reflects that the Revised Social Anhedonia
 
Scale taps both dimensions or that the 
schizotypy dimensions
 
are significantly associated. Obviously, the present study cannot
 
definitively disentangle 
this issue. However, given both the
 
conceptual and empirical information noted above, we suggest
 
that the most 
parsimonious explanation is that this represents
 
a measurement issue and that a purer measure of the construct
 
would not load on both dimensions—allowing us to better
 
understand the relationship between the positive and 
negative
 
schizotypy dimensions. Given that social anhedonia is firmly
 
rooted in negative symptom schizotypy, 
the results suggest that
 
the Revised Social Anhedonia Scale is actually a better multidimensional
 
measure of 
schizotypy than a pure measure of the negative dimension.
 
 
Beyond Positive and Negative Schizotypy Dimensions 
The present findings support further theoretical and empirical
 
examination of the multidimensional structure of 
schizotypy.
 
However, this obviously raises the conceptual question about
 
which dimensions underlie 
schizotypy, and of these, which can
 
be successfully assessed via self-report measures. The schizophrenia
 
and 
schizotypy literatures suggest that positive symptoms of
 
clinical and subclinical deviance can be readily 
identified
 
by self-report (in fact, nonpsychotic individuals may be better
 
able to recognize the deviant nature of 
unusual perceptual experiences
 
and magical beliefs because their connection to reality is presumed
 
to be more 
intact than their psychotic counterparts). Likewise,
 
schizotypic individuals appear readily able to report on a 
number
 
of negative features such as social disinterest, diminished
 
affect, avolition, and anhedonia. However, 
questionnaire measures
 
have not proven as successful at assessing mild forms of formal
 
thought disturbance and 
cognitive disorganization. This may
 
reflect that the disturbance itself impedes participants’
 
ability to recognize 
and report such impairment, as well as
 
the fact that formal thought disturbance may only become manifest
 
at 
more extreme (clinical) ends of the distribution of schizotypy.
 
Similarly, behavioral disorganization (as opposed 
to purposefully
 
nonconforming behavior) may be less accessible to self-report
 
assessments than to observer 
ratings. Building on Eysenck's
 
conceptualization of psychoticism, several measures have been
 
developed to 
assess impulsive nonconformity as a dimension of
 
schizotypy.52,68,69 However, empirical findings have not 
generally
 
supported the inclusion of this dimension.70 The present study
 
found that interview ratings of 
paranoid experiences are associated
 
with both positive and negative schizotypy. In contrast, Stefanis
 
et al13 
found support for a separate paranoid dimension of schizotypy.
 
Furthermore, a number of promising new 
measures of paranoid
 
ideation and behaviors have been recently developed, including
 
the Paranoia Checklist71 
and the Paranoia Scale.72 Given that
 
schizotypy is conceptualized as multidimensional, it will be
 
important that 
new measures focus on assessing the severity
 
of these dimensions across a broad range of severity.
 
 
The late 1970s to mid 1990s saw the creation of a number of
 
psychometric inventories designed to assess 
aspects of schizotypy
 
(under many different guises). Since that time, interest has
 
focused more on the 
development of interview measures of schizotypic
 
symptoms and impairment such as the Structured Interview 
for
 
Prodromal Symptoms73 and Comprehensive Assessment of At-Risk
 
Mental States,74 and the Negative 
Symptom Manual. It is important
 
to note that while these interviews are especially useful for
 
providing 
quantitative ratings of the severity of schizotypic
 
impairment, they are not practical as first-line screening 
measures
 
of schizotypy given the time and expertise that they require
 
to administer. A considerable amount of 
cross-sectional data
 
have been collected with psychometric screening questionnaires
 
(and summarized 
elsewhere) allowing us to assess their basic
 
psychometric properties as well as to evaluate their relationship
 
with 
neurocognitive, affective, and social impairment and a
 
wide array of clinical symptoms. However, these 
measures are
 
simply tools that bear reevaluation (and almost certainly refinement).
 
 
Researchers should bear in mind that the development and use
 
of psychometric screening assessments is still a 
work in progress
 
that aims at a moving target (the construct of schizotypy).
 
Ideally, our understanding of the 
construct should inform the
 
development of measures, and the findings from employing the
 
measures should 
refine our understanding and assessment of the
 
construct. Again, this means that our measures simply provide
 
a 
point of entry for studying schizotypy that should be used
 
in conjunction with measures of neurophysiological, 
neurocognitive,
 
behavioral, social, and emotional functioning and impairment.
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